THE FAMILIAL SPORADIC DISTINCTION AS A STRATEGY IN SCHIZOPHRENIA RESEARCHBRITISH JOURNAL OF PSYCHIATRYIF7.62018-01-0291PREAI
TOXIC SEROTONIN SYNDROME OR ESTRAPYRAMIDAL SIDE-EFFECTSBRITISH JOURNAL OF PSYCHIATRYIF7.62018-01-0213OAAI
Measuring memory impairment in community-based patients with schizophrenia - Case-control studyBRITISH JOURNAL OF PSYCHIATRYIF7.62018-01-0218OAAI
AGENESIS OF THE CORPUS-CALLOSUM AND SCHIZOPHRENIA - A CASE-REPORTPSYCHOLOGICAL MEDICINEIF5.52009-07-0949PREAI
SACCADIC ABNORMALITIES IN PSYCHOTIC-PATIENTS .1. NEUROLEPTIC-FREE PSYCHOTIC-PATIENTSPSYCHOLOGICAL MEDICINEIF5.52009-07-09152PRE
SACCADIC ABNORMALITIES IN PSYCHOTIC-PATIENTS .2. THE ROLE OF NEUROLEPTIC TREATMENTPSYCHOLOGICAL MEDICINEIF5.52009-07-0989PRE
Abnormal prediction error is associated with negative and depressive symptoms in schizophreniaPROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYIF3.92008-01-0132PREAI
Prevalence and measurement of memory impairment in schizophreniaSCHIZOPHRENIA RESEARCHIF3.52003-03-010PREAI
Reduced Kamin blocking in non paranoid schizophrenia: associations with schizotypyJOURNAL OF PSYCHIATRIC RESEARCHIF3.22003-03-0155PREAI
Reduced frontal activation during verbal fluency in schizophrenia: An fMRI studySCHIZOPHRENIA RESEARCHIF3.52000-01-010PREAI
Oestrogen improves dysfunction of the frontocortico-striatal network (FCSN) during menopauseSCHIZOPHRENIA RESEARCHIF3.51998-01-010PREAI
Risperidone improves antisaccade error rates in schizophreniaSCHIZOPHRENIA RESEARCHIF3.51998-01-015PREAI
Pharmacologic effects on antisaccade abnormalities in first episode and chronic schizophreniaSCHIZOPHRENIA RESEARCHIF3.51998-01-010PREAI
CYTOMEGALO-VIRUS AND SCHIZOPHRENIA - A TEST OF THE VIROLOGICAL HYPOTHESISPROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYIF3.91985-01-010PREAI